epigallocatechin gallate has been researched along with vorinostat in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Miyata, N; Suzuki, T | 1 |
| Nihal, M; Roelke, CT; Wood, GS | 1 |
| Jordan, HR; Steed, KL; Tollefsbol, TO | 1 |
1 review(s) available for epigallocatechin gallate and vorinostat
| Article | Year |
|---|---|
Lysine demethylases inhibitors.
Topics: Animals; Flavins; Histone Demethylases; Humans; Jumonji Domain-Containing Histone Demethylases; Models, Molecular; Protein Conformation | 2011 |
2 other study(ies) available for epigallocatechin gallate and vorinostat
| Article | Year |
|---|---|
Anti-melanoma effects of vorinostat in combination with polyphenolic antioxidant (-)-epigallocatechin-3-gallate (EGCG).
Topics: Anticarcinogenic Agents; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Catechin; Cell Cycle; Cell Line, Tumor; Cell Proliferation; eIF-2 Kinase; Gene Expression Regulation, Neoplastic; Humans; Hydroxamic Acids; Melanoma; NF-kappa B; Vorinostat | 2010 |
SAHA and EGCG Promote Apoptosis in Triple-negative Breast Cancer Cells, Possibly Through the Modulation of cIAP2.
Topics: Apoptosis; Baculoviral IAP Repeat-Containing 3 Protein; Caspase 7; Catechin; Cell Cycle; Cell Line, Tumor; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Female; Gene Expression Regulation, Neoplastic; Humans; Triple Negative Breast Neoplasms; Vorinostat | 2020 |